Browsing: Eyenovia

(Reuters) -Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and…

Eyenovia, Inc. (NASDAQ:), a biopharmaceutical company specializing in ophthalmic diseases, announced its financial results for the first quarter ended March…